An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models.
- DOI
- 10.1038/mtm.2014.44
- Published
- 2014
- Container
- Molecular therapy. Methods & clinical development
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/mtm.2014.44,
title = {An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models.},
author = {Gérard C and Xiao X and Filali M and Coulombe Z and Arsenault M and Couet J and Li J and Drolet MC and Chapdelaine P and Chikh A and Tremblay JP},
year = {2014},
journal = {Molecular therapy. Methods \& clinical development},
doi = {10.1038/mtm.2014.44},
url = {https://doi.org/10.1038/mtm.2014.44}
}RIS
TY - JOUR TI - An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models. AU - Gérard C AU - Xiao X AU - Filali M AU - Coulombe Z AU - Arsenault M AU - Couet J AU - Li J AU - Drolet MC AU - Chapdelaine P AU - Chikh A AU - Tremblay JP PY - 2014 JO - Molecular therapy. Methods & clinical development DO - 10.1038/mtm.2014.44 UR - https://doi.org/10.1038/mtm.2014.44 ER -
APA
C, G., X, X., M, F., Z, C., M, A., J, C., J, L., MC, D., P, C., A, C., & JP, T. (2014). An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models.. Molecular therapy. Methods & clinical development. https://doi.org/10.1038/mtm.2014.44
Source records
- pubmed · retrieved 2026-09-27T08:43:03.037Z